|
Friday April 13th, 2007
|
|
|
13.30 -
14.30 |
Arrival, exhibition and coffee |
|
|
|
|
|
|
14.30 -
15.30 |
Claus Brun lecture:
A risk and benefit assessment of living kidney donation |
Anders Hartmann
Oslo, Norge
|
|
|
15.30 -
16.00 |
UK Transplant:
Organisation and results
(including data from the national potential donor audit) |
Chris Rudge
Managing and transplant director.
Bristol, UK |
|
|
|
|
|
16.00 - 16.30 |
Break, exhibition and coffee |
|
|
|
|
|
|
16.30 - 17.00 |
Estimating the organ donor potential in Denmark: A
prospective analysis of deaths in intensive care units in
northern Denmark
|
Lone Bøgh
and
Kaj Anker Jørgensen
Aarhus |
|
|
17.00 -
17.15 |
Discussion
|
|
|
|
17.15 - 17.45 |
National Registry: Rapport 2006 |
James Heaf and Hans Dieperink |
|
|
|
|
|
18.00 -
18.30 |
Registration at ARoS
www.aros.dk
|
|
|
|
18.30 -
19.30 |
Visiting ARoS
|
|
|
|
19.30 -
23.45 |
Dinner at ARoS, ART Restaurant. Level 8
|
|
|
|
|
|
|
Saturday April 14th, 2007
|
|
|
09.00 -
09.45 |
Renal albumin handling in physiology and pathology |
Erik Ilsø
Christensen
Aarhus, Denmark
|
|
|
09.45 - 10.30 |
ABO-incompatible Kidney Transplantation |
Gunnar Tydén, Stockholm |
|
|
|
|
|
10.30 – 11.15 |
Break, exhibition and coffee |
|
|
|
|
|
|
Frie foredrag: Chairman Claus Bistrup |
|
|
|
|
|
11.15 – 11.26 |
Hornum M,
Clausen P, Hansen JM, Mathiesen E, Feldt-Rasmussen B.
The endothelial dependent flow-mediated dilatory response is
delayed in patients with chronic renal failure on the
transplantation waiting list as compared to patients
awaiting living donor transplantation; an association with
duration of ESRD?
|
|
|
11.26 –
11.37 |
Frimodt-Møller M,
Nielsen AH, Kamper AL, Strandgaard S.
Reproducibility of pulse-wave analysis and pulse-wave
velocity
|
|
|
11.37 – 11.48 |
Wang D, Iversen J, Leone A, Connors SG, Strandgaard
S, Wilcox CS.
Asymmetric Dimethylarginine, 13-Hydroxyoctadecadienoic Acid
and EDRF/NO in Patients with Essential Hypertension
|
|
|
11.48 –
11.59 |
Madsen MB,
Lindeborg L, Hansen HE, Ivarsen P, Povlsen JV.
Complications related to ultrasound-guided percutaneous
renal biopsies: A retrospective single center study
|
|
|
11.59 – 12.10 |
Strandhave C,
Søndergaard E, Pedersen RS, Bendix K, d´Amore F, Jørgensen
KA
A
Single-centre Experience of Clinico-Pathological Features,
Risk Factors and Treatment Outcome of Posttransplant
Lymphoproliferative Disorders (PTLD) after Renal
Transplantation
|
|
|
12.10 – 12.21 |
Hornum M,
Mortensen KL, Kamper AL, Andersen ÅB.
Limitations of the QuantiFERONâ
–TB Gold test in detecting Mycobacterium tuberculosis
infection in immunocompromised patients
|
|
|
12.21 – 12.32 |
Larsen JJ,
Mersebach H, Sørensen SS, Rasmussen ÅK, Hasholt L, Feldt-Rasmussen
U.
Kidney function in Danish Fabry patients treated with
a-Galactosidase
A infusion
|
|
|
12.32 – 12.43 |
Heaf J.
1.73
m2
=
1.92 m2 |
|
|
|
|
|
12.45 – 13.45 |
Lunch |
|
|
|
|
|
|
Frie
foredrag (fortsat) Chairman: Jens Dam Jensen
|
|
|
13.45 – 13.56 |
Sørensen VR,
Mathiesen ER, Watt T, Bjorner JB, Andersen N,
Feldt-Rasmussen B.
Diabetic patients treated with dialysis: Complications and
quality of life
|
|
|
13.56
– 14.07 |
Sørensen
VR,
Mathiesen ER, Heaf J, Feldt-Rasmussen B.
Improved survival rates in patients with diabetes and
end-stage renal disease in Denmark
|
|
|
14.07– 14.18 |
Feldt-Rasmussen B,
Lange M, Sulowicz, Gafter U, Lai KN, Wiedemann J,
Christiansen JS, Nahas ME.
Improvement of lean body mass, other predictors of mortality
and quality of life during growth hormone treatment in
patients on chronic haemodialysis: Results from a
randomised, double-blind, placebo-controlled trial
|
|
|
14.18 – 14.29 |
Honkanen E, Jensen PB, Kauppila L, Wikstrom B, Rensma
PL, Krzesinski JM, Aasarod K, Verbeke F, Rasmussen M, Volck
B.
Calcification Outcome in Renal Disease (CORD) – a
prospective epidemiological multinational study: Baseline
parameters of abdominal aorta calcification score in
dialysis patients
|
|
|
14.29
– 14.40 |
Pedersen
KR, Pedersen J. Hjortholm K, Christensen S, Larsen SH,
Hjortdal VE, Povlsen JV.
Acute renal failure managed with peritoneal dialysis after
surgery for congenital heart disease in children
|
|
|
14.40 – 14.51 |
Szpirt WM,
Krarup E, Egfjord M.
Saving effect of plasma exchange on cyclophosphamide dose in
induction treatment in ANCA-associated systemic vasculitis
|
|
|
14.51 – 15.02 |
Damholt MB,
Meert N, Vanholder R, Dethloff T, Feldt-Rasmussen B,
Ladefoged SD.
First report of efficient removal of protein bound uremic
toxins in chronic hemodialysis patients by modified plasma
separation and adsorption combined with hemodialysis (mFPSA)
|
|
|
|
|
|
15.00 -
15.30 |
Break,
exhibition and coffee
|
|
|
|
|
|
|
15. 30 -
16.30 |
General
assembly
Herunder
1)
Uddeling af 2 Roche legater til Boston uddannelsen
2)
Uddeling af priser til 2 vindere af årets
foredragskonkurrence.
Priserne
er henholdsvis:
-
En
kongresrejse til ASN efteråret 2007, sponsoreret af Janssen-Cilag
-
Den
anden pris er sponsoreret af ERA-EDTA og består i en
kongresrejse til EDTA-kongressen 2008 samt 3 års gratis
medlemskab af ERA-EDTA.
Overrækkelse af diplom til 2006 vinderen af ERA-EDTA-prisen
Signe Hjorth
|
|
|
|
|
|
Årsmødet
er sponseret af:
Amgen AB -
Roche - Gambro Danmark, filial af Gambro Lundi AB -
Janssen-Cilag - Novartis - Abbot - Astellas Pharma |
|
|
|
| |
|
|
|
|
|